IBDEI09U ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13192,2)
 ;;=^330078
 ;;^UTILITY(U,$J,358.3,13193,0)
 ;;=282.63^^83^833^51
 ;;^UTILITY(U,$J,358.3,13193,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13193,1,1,0)
 ;;=1^282.63
 ;;^UTILITY(U,$J,358.3,13193,1,8,0)
 ;;=8^Sickle-cell/Hb-C Dis w/o Crisis
 ;;^UTILITY(U,$J,358.3,13193,2)
 ;;=^330080
 ;;^UTILITY(U,$J,358.3,13194,0)
 ;;=282.64^^83^833^50
 ;;^UTILITY(U,$J,358.3,13194,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13194,1,1,0)
 ;;=1^282.64
 ;;^UTILITY(U,$J,358.3,13194,1,8,0)
 ;;=8^Sickle-cell/Hb-C Dis w/ Crisis
 ;;^UTILITY(U,$J,358.3,13194,2)
 ;;=^329911
 ;;^UTILITY(U,$J,358.3,13195,0)
 ;;=282.68^^83^833^38
 ;;^UTILITY(U,$J,358.3,13195,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13195,1,1,0)
 ;;=1^282.68
 ;;^UTILITY(U,$J,358.3,13195,1,8,0)
 ;;=8^Oth Sickle-cell Dis w/o Crisis
 ;;^UTILITY(U,$J,358.3,13195,2)
 ;;=^329912
 ;;^UTILITY(U,$J,358.3,13196,0)
 ;;=282.69^^83^833^37
 ;;^UTILITY(U,$J,358.3,13196,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13196,1,1,0)
 ;;=1^282.69
 ;;^UTILITY(U,$J,358.3,13196,1,8,0)
 ;;=8^Oth Sickle-cell Dis w/ Crisis
 ;;^UTILITY(U,$J,358.3,13196,2)
 ;;=^330081
 ;;^UTILITY(U,$J,358.3,13197,0)
 ;;=282.7^^83^833^34
 ;;^UTILITY(U,$J,358.3,13197,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13197,1,1,0)
 ;;=1^282.7
 ;;^UTILITY(U,$J,358.3,13197,1,8,0)
 ;;=8^Oth Hemoglobinopathies
 ;;^UTILITY(U,$J,358.3,13197,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,13198,0)
 ;;=282.8^^83^833^40
 ;;^UTILITY(U,$J,358.3,13198,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13198,1,1,0)
 ;;=1^282.8
 ;;^UTILITY(U,$J,358.3,13198,1,8,0)
 ;;=8^Oth Spec Hereditary Hemolytic
 ;;^UTILITY(U,$J,358.3,13198,2)
 ;;=^267984
 ;;^UTILITY(U,$J,358.3,13199,0)
 ;;=283.10^^83^833^31
 ;;^UTILITY(U,$J,358.3,13199,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13199,1,1,0)
 ;;=1^283.10
 ;;^UTILITY(U,$J,358.3,13199,1,8,0)
 ;;=8^Non-autoimmune Hemolytic Anemia
 ;;^UTILITY(U,$J,358.3,13199,2)
 ;;=^294004
 ;;^UTILITY(U,$J,358.3,13200,0)
 ;;=283.11^^83^833^22
 ;;^UTILITY(U,$J,358.3,13200,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13200,1,1,0)
 ;;=1^283.11
 ;;^UTILITY(U,$J,358.3,13200,1,8,0)
 ;;=8^Hemolytic-uremic Syndrome
 ;;^UTILITY(U,$J,358.3,13200,2)
 ;;=^293663
 ;;^UTILITY(U,$J,358.3,13201,0)
 ;;=285.0^^83^833^52
 ;;^UTILITY(U,$J,358.3,13201,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13201,1,1,0)
 ;;=1^285.0
 ;;^UTILITY(U,$J,358.3,13201,1,8,0)
 ;;=8^Sideroblastic Anemia
 ;;^UTILITY(U,$J,358.3,13201,2)
 ;;=^7204
 ;;^UTILITY(U,$J,358.3,13202,0)
 ;;=285.3^^83^833^9
 ;;^UTILITY(U,$J,358.3,13202,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13202,1,1,0)
 ;;=1^285.3
 ;;^UTILITY(U,$J,358.3,13202,1,8,0)
 ;;=8^Antineoplastic Chemo Ind Anemia
 ;;^UTILITY(U,$J,358.3,13202,2)
 ;;=^338232
 ;;^UTILITY(U,$J,358.3,13203,0)
 ;;=285.8^^83^833^39
 ;;^UTILITY(U,$J,358.3,13203,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13203,1,1,0)
 ;;=1^285.8
 ;;^UTILITY(U,$J,358.3,13203,1,8,0)
 ;;=8^Oth Spec Anemia
 ;;^UTILITY(U,$J,358.3,13203,2)
 ;;=^87876
 ;;^UTILITY(U,$J,358.3,13204,0)
 ;;=283.2^^83^833^21
 ;;^UTILITY(U,$J,358.3,13204,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13204,1,1,0)
 ;;=1^283.2
 ;;^UTILITY(U,$J,358.3,13204,1,8,0)
 ;;=8^Hemolytic d/t Hemolysis
 ;;^UTILITY(U,$J,358.3,13204,2)
 ;;=^55770
 ;;^UTILITY(U,$J,358.3,13205,0)
 ;;=280.0^^83^833^27
 ;;^UTILITY(U,$J,358.3,13205,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13205,1,1,0)
 ;;=1^280.0
 ;;^UTILITY(U,$J,358.3,13205,1,8,0)
 ;;=8^Iron Def Anemia,d/t Blood Loss Anemia
 ;;^UTILITY(U,$J,358.3,13205,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,13206,0)
 ;;=280.1^^83^833^28
 ;;^UTILITY(U,$J,358.3,13206,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13206,1,1,0)
 ;;=1^280.1
 ;;^UTILITY(U,$J,358.3,13206,1,8,0)
 ;;=8^Iron Def Anemia,d/t Dietary Intake
 ;;^UTILITY(U,$J,358.3,13206,2)
 ;;=^267972
 ;;^UTILITY(U,$J,358.3,13207,0)
 ;;=280.8^^83^833^26
 ;;^UTILITY(U,$J,358.3,13207,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13207,1,1,0)
 ;;=1^280.8
 ;;^UTILITY(U,$J,358.3,13207,1,8,0)
 ;;=8^Iron Def Anemia,Oth Spec
 ;;^UTILITY(U,$J,358.3,13207,2)
 ;;=^88088
 ;;^UTILITY(U,$J,358.3,13208,0)
 ;;=284.09^^83^833^13
 ;;^UTILITY(U,$J,358.3,13208,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13208,1,1,0)
 ;;=1^284.09
 ;;^UTILITY(U,$J,358.3,13208,1,8,0)
 ;;=8^Constitutional Aplastic Anemia,Oth
 ;;^UTILITY(U,$J,358.3,13208,2)
 ;;=^334036
 ;;^UTILITY(U,$J,358.3,13209,0)
 ;;=286.9^^83^834^9
 ;;^UTILITY(U,$J,358.3,13209,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13209,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,13209,1,8,0)
 ;;=8^Defective Coagulation,Unspec
 ;;^UTILITY(U,$J,358.3,13209,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,13210,0)
 ;;=446.6^^83^834^26
 ;;^UTILITY(U,$J,358.3,13210,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13210,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,13210,1,8,0)
 ;;=8^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,13210,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,13211,0)
 ;;=451.9^^83^834^25
 ;;^UTILITY(U,$J,358.3,13211,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13211,1,1,0)
 ;;=1^451.9
 ;;^UTILITY(U,$J,358.3,13211,1,8,0)
 ;;=8^Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,13211,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,13212,0)
 ;;=287.5^^83^834^23
 ;;^UTILITY(U,$J,358.3,13212,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13212,1,1,0)
 ;;=1^287.5
 ;;^UTILITY(U,$J,358.3,13212,1,8,0)
 ;;=8^Thrombocytopenia Nos
 ;;^UTILITY(U,$J,358.3,13212,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,13213,0)
 ;;=287.30^^83^834^21
 ;;^UTILITY(U,$J,358.3,13213,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13213,1,1,0)
 ;;=1^287.30
 ;;^UTILITY(U,$J,358.3,13213,1,8,0)
 ;;=8^Primary Thrombocytopenia (ITP)
 ;;^UTILITY(U,$J,358.3,13213,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,13214,0)
 ;;=238.71^^83^834^24
 ;;^UTILITY(U,$J,358.3,13214,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13214,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,13214,1,8,0)
 ;;=8^Thrombocytosis,Essential
 ;;^UTILITY(U,$J,358.3,13214,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,13215,0)
 ;;=286.53^^83^834^4
 ;;^UTILITY(U,$J,358.3,13215,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13215,1,1,0)
 ;;=1^286.53
 ;;^UTILITY(U,$J,358.3,13215,1,8,0)
 ;;=8^Antiphospholipid w/ Hemor d/o
 ;;^UTILITY(U,$J,358.3,13215,2)
 ;;=^340503
 ;;^UTILITY(U,$J,358.3,13216,0)
 ;;=286.0^^83^834^7
 ;;^UTILITY(U,$J,358.3,13216,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13216,1,1,0)
 ;;=1^286.0
 ;;^UTILITY(U,$J,358.3,13216,1,8,0)
 ;;=8^Congenital Factor VII Disorder
 ;;^UTILITY(U,$J,358.3,13216,2)
 ;;=^27454
 ;;^UTILITY(U,$J,358.3,13217,0)
 ;;=286.1^^83^834^5
 ;;^UTILITY(U,$J,358.3,13217,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13217,1,1,0)
 ;;=1^286.1
 ;;^UTILITY(U,$J,358.3,13217,1,8,0)
 ;;=8^Cogenital Factor IX Disorder
 ;;^UTILITY(U,$J,358.3,13217,2)
 ;;=^27452
 ;;^UTILITY(U,$J,358.3,13218,0)
 ;;=286.2^^83^834^8
 ;;^UTILITY(U,$J,358.3,13218,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13218,1,1,0)
 ;;=1^286.2
 ;;^UTILITY(U,$J,358.3,13218,1,8,0)
 ;;=8^Congenital Factor XI Deficiency
 ;;^UTILITY(U,$J,358.3,13218,2)
 ;;=^27456
 ;;^UTILITY(U,$J,358.3,13219,0)
 ;;=286.3^^83^834^6
 ;;^UTILITY(U,$J,358.3,13219,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13219,1,1,0)
 ;;=1^286.3
 ;;^UTILITY(U,$J,358.3,13219,1,8,0)
 ;;=8^Congenital Def of Oth Clotting
 ;;^UTILITY(U,$J,358.3,13219,2)
 ;;=^27437
 ;;^UTILITY(U,$J,358.3,13220,0)
 ;;=286.4^^83^834^28
 ;;^UTILITY(U,$J,358.3,13220,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13220,1,1,0)
 ;;=1^286.4
 ;;^UTILITY(U,$J,358.3,13220,1,8,0)
 ;;=8^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,13220,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,13221,0)
 ;;=286.52^^83^834^2
 ;;^UTILITY(U,$J,358.3,13221,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13221,1,1,0)
 ;;=1^286.52
 ;;^UTILITY(U,$J,358.3,13221,1,8,0)
 ;;=8^Acquired Hemophilia
 ;;^UTILITY(U,$J,358.3,13221,2)
 ;;=^340502
 ;;^UTILITY(U,$J,358.3,13222,0)
 ;;=286.59^^83^834^16
 ;;^UTILITY(U,$J,358.3,13222,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13222,1,1,0)
 ;;=1^286.59
 ;;^UTILITY(U,$J,358.3,13222,1,8,0)
 ;;=8^Oth Hemor d/o d/t Anticoagulant
 ;;^UTILITY(U,$J,358.3,13222,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,13223,0)
 ;;=286.6^^83^834^10
 ;;^UTILITY(U,$J,358.3,13223,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13223,1,1,0)
 ;;=1^286.6
 ;;^UTILITY(U,$J,358.3,13223,1,8,0)
 ;;=8^Defibrination Syndrome
 ;;^UTILITY(U,$J,358.3,13223,2)
 ;;=^35673
 ;;^UTILITY(U,$J,358.3,13224,0)
 ;;=286.7^^83^834^1
 ;;^UTILITY(U,$J,358.3,13224,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13224,1,1,0)
 ;;=1^286.7
 ;;^UTILITY(U,$J,358.3,13224,1,8,0)
 ;;=8^Acquired Coagulation Factor Def
 ;;^UTILITY(U,$J,358.3,13224,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,13225,0)
 ;;=287.0^^83^834^3
 ;;^UTILITY(U,$J,358.3,13225,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13225,1,1,0)
 ;;=1^287.0
 ;;^UTILITY(U,$J,358.3,13225,1,8,0)
 ;;=8^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,13225,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,13226,0)
 ;;=287.1^^83^834^22
 ;;^UTILITY(U,$J,358.3,13226,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13226,1,1,0)
 ;;=1^287.1
 ;;^UTILITY(U,$J,358.3,13226,1,8,0)
 ;;=8^Qualitative Platelet Defects
 ;;^UTILITY(U,$J,358.3,13226,2)
 ;;=^101922
 ;;^UTILITY(U,$J,358.3,13227,0)
 ;;=287.2^^83^834^17
 ;;^UTILITY(U,$J,358.3,13227,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13227,1,1,0)
 ;;=1^287.2
 ;;^UTILITY(U,$J,358.3,13227,1,8,0)
 ;;=8^Oth Nonthrombocytopenic Purpuras
 ;;^UTILITY(U,$J,358.3,13227,2)
 ;;=^87741
 ;;^UTILITY(U,$J,358.3,13228,0)
 ;;=287.31^^83^834^13
 ;;^UTILITY(U,$J,358.3,13228,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13228,1,1,0)
 ;;=1^287.31
 ;;^UTILITY(U,$J,358.3,13228,1,8,0)
 ;;=8^Immune Thrombocytopenic Purpura
 ;;^UTILITY(U,$J,358.3,13228,2)
 ;;=^332746
 ;;^UTILITY(U,$J,358.3,13229,0)
 ;;=287.32^^83^834^11
 ;;^UTILITY(U,$J,358.3,13229,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13229,1,1,0)
 ;;=1^287.32
